Lessons from COVID-19
2019-nCoV, nitrosamine issues trigger supply chain re-jigs
2019-nCoV must reform India Pharma Inc
2019-nCoV: A wake-up call
Will Budget 2020 be a salve or a sting for India Pharma Inc?
Why API price needs to be part of NPPA’s pricing formula
Will regulators catch up in 2020?
Rationalising pharma trade margins seems next on the list
Lupin sells stakes in Kyowa but its not a Sayonara
After sartans and ranitidine, where will NDMA show up next?
Page 1 of 13
Page 13 of 13